Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 2 | 2022 | 5 | 1.670 |
Why?
|
| Nephrotic Syndrome | 2 | 2022 | 17 | 1.660 |
Why?
|
| Anemia | 3 | 2019 | 68 | 0.710 |
Why?
|
| Patient Preference | 1 | 2019 | 36 | 0.630 |
Why?
|
| Workplace | 1 | 2019 | 95 | 0.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 488 | 0.490 |
Why?
|
| Proteinuria | 3 | 2022 | 39 | 0.470 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 44 | 0.360 |
Why?
|
| Glomerulonephritis | 1 | 2008 | 13 | 0.310 |
Why?
|
| Child | 8 | 2022 | 6847 | 0.310 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 46 | 0.300 |
Why?
|
| Kidney | 4 | 2018 | 665 | 0.280 |
Why?
|
| Hypertension | 3 | 2018 | 533 | 0.250 |
Why?
|
| Hypertension, Renovascular | 1 | 2004 | 14 | 0.250 |
Why?
|
| Obesity | 2 | 2010 | 1113 | 0.240 |
Why?
|
| Nephrosis, Lipoid | 1 | 2003 | 5 | 0.230 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2003 | 10 | 0.230 |
Why?
|
| Kidney Diseases | 1 | 2004 | 214 | 0.210 |
Why?
|
| Pyelonephritis | 1 | 2002 | 5 | 0.200 |
Why?
|
| Humans | 16 | 2022 | 49974 | 0.200 |
Why?
|
| Adolescent | 9 | 2018 | 6356 | 0.200 |
Why?
|
| Adult | 4 | 2022 | 13236 | 0.200 |
Why?
|
| Risk Factors | 4 | 2019 | 3613 | 0.190 |
Why?
|
| Amoxicillin | 1 | 2020 | 21 | 0.180 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 175 | 0.170 |
Why?
|
| Ureteral Obstruction | 1 | 2020 | 60 | 0.170 |
Why?
|
| Indonesia | 1 | 2019 | 5 | 0.170 |
Why?
|
| Child, Preschool | 6 | 2008 | 3871 | 0.160 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 7 | 0.160 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2018 | 4 | 0.160 |
Why?
|
| Focus Groups | 1 | 2019 | 190 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2018 | 114 | 0.150 |
Why?
|
| Infant | 5 | 2020 | 3567 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2019 | 329 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 284 | 0.140 |
Why?
|
| Female | 9 | 2019 | 26472 | 0.140 |
Why?
|
| Male | 11 | 2020 | 25241 | 0.130 |
Why?
|
| Urinary Diversion | 1 | 2015 | 44 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 744 | 0.120 |
Why?
|
| Acute Disease | 2 | 2008 | 366 | 0.120 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 1037 | 0.100 |
Why?
|
| Epiphyses, Slipped | 1 | 2010 | 5 | 0.090 |
Why?
|
| Osteochondrosis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 14 | 0.090 |
Why?
|
| Femur Head | 1 | 2010 | 26 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2010 | 107 | 0.090 |
Why?
|
| Biopsy | 3 | 2018 | 584 | 0.080 |
Why?
|
| Nephritis | 2 | 2018 | 22 | 0.080 |
Why?
|
| Arthritis | 2 | 2018 | 42 | 0.080 |
Why?
|
| Impetigo | 1 | 2008 | 3 | 0.080 |
Why?
|
| Urticaria | 2 | 2018 | 18 | 0.080 |
Why?
|
| Arthralgia | 2 | 2018 | 43 | 0.080 |
Why?
|
| Pharyngitis | 1 | 2008 | 16 | 0.080 |
Why?
|
| Florida | 1 | 2008 | 58 | 0.080 |
Why?
|
| Exanthema | 2 | 2018 | 32 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2015 | 984 | 0.080 |
Why?
|
| Seasons | 1 | 2008 | 81 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2018 | 81 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2010 | 6108 | 0.070 |
Why?
|
| Hyperuricemia | 1 | 2007 | 5 | 0.070 |
Why?
|
| Graft Survival | 1 | 2008 | 150 | 0.070 |
Why?
|
| Uric Acid | 1 | 2007 | 21 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2008 | 161 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2006 | 40 | 0.070 |
Why?
|
| Age of Onset | 1 | 2006 | 108 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 310 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 109 | 0.070 |
Why?
|
| Phosphates | 1 | 2005 | 47 | 0.060 |
Why?
|
| Peritoneal Dialysis | 1 | 2005 | 33 | 0.060 |
Why?
|
| Urography | 1 | 2004 | 26 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1003 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 945 | 0.060 |
Why?
|
| Time Factors | 2 | 2008 | 2903 | 0.060 |
Why?
|
| Edema | 1 | 2003 | 67 | 0.050 |
Why?
|
| Succimer | 1 | 2002 | 2 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 302 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2002 | 92 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2002 | 116 | 0.050 |
Why?
|
| Urethra | 1 | 2002 | 89 | 0.050 |
Why?
|
| Radiography | 1 | 2002 | 489 | 0.050 |
Why?
|
| Crystallization | 1 | 2020 | 32 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 436 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2018 | 3 | 0.040 |
Why?
|
| Myeloblastin | 1 | 2018 | 3 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 18 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2018 | 38 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 377 | 0.040 |
Why?
|
| Appendix | 1 | 2015 | 22 | 0.030 |
Why?
|
| Ureter | 1 | 2015 | 37 | 0.030 |
Why?
|
| Necrosis | 1 | 2015 | 176 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2182 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 139 | 0.020 |
Why?
|
| Urate Oxidase | 1 | 2007 | 5 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2007 | 9 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2008 | 5141 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 402 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2007 | 76 | 0.020 |
Why?
|
| Phosphorus | 1 | 2005 | 27 | 0.020 |
Why?
|
| Registries | 1 | 2008 | 522 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 147 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 1259 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 396 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 449 | 0.010 |
Why?
|